eChapters

Tissue Doppler Imaging

Doppler echocardiography relies on detection of the shift in frequency of ultrasound signals reflected from moving objects. With this principle, conventional Doppler techniques assess the velocity of blood flow by measuring high-frequency, low amplitude signals from small, fast-moving blood cells. In TDI, the same Doppler principles are used to quantify the higher-amplitude, lower-velocity signals of myocardial tissue motion.

There are important limitations to TD interrogation. As with all Doppler techniques, TDI measures only the vector of motion that is parallel to the direction of the ultrasound beam. In addition, TDI measures absolute tissue velocity and is unable to discriminate passive motion (related to translation or tethering) from active motion (fiber shortening or lengthening). The emerging technology of Doppler strain imaging provides a means to differentiate true contractility from passive myocardial motion by looking at relative changes in tissue velocity.

1. Introduction:- Understanding Good Laboratory Practices (GLP)
1.1 Definition and Core Principles of GLP
The Organisation for Economic Co-operation and Development (OECD) defines Good Laboratory Practice as “a managerial quality control system that governs the organizational process and the conditions under which non-clinical health and thus, environmental safety studies are well planned, executed/ performed, vigilantly monitored, properly recorded, reported, and finally archived”. This definition highlights that Good Laboratory Practices (GLP) is a comprehensive framework focused on ensuring the quality and integrity of the entire study lifecycle, rather than dictating the scientific validity of the research itself. The primary goal of GLP is to ensure process integrity and data traceability, which are essential for the regulatory acceptance of safety data for a variety of products. These products include pharmaceuticals, pesticides, cosmetics, veterinary drugs, food additives, feed additives, and industrial chemicals, all of which undergo non-clinical testing to assess their potential health and environmental risks. It is important to note that GLP principles specifically apply to these non-clinical studies and exclude research involving human subjects. The OECD Principles of GLP are internationally recognized and serve as the basis for GLP regulations in numerous countries worldwide. These principles outline the responsibilities of key personnel involved in non-clinical studies, including test facility management, the study director, study personnel, and quality assurance personnel. Furthermore, they establish minimum standards concerning the suitability of facilities and equipment to perform studies, as well as the necessity for comprehensive Standard Operating Procedures (SOPs) to guide all aspects of laboratory operations. The core principles of GLP encompass a wide range of elements critical to ensuring the quality and integrity of laboratory studies. These OECD principles of Good Laboratory Practices (GLP) include: the proper organization team and personnel staff members within the testing facility, the well establishment of a robust quality assurance programme, the better suitability and proper maintenance of various necessary facilities, the efficient management of apparatus, materials, and reagents, the characterization and control of test systems, the handling of test and reference items, the development and adherence to Standard Operating

ABSTRACT

Solanum trilobatum Linn. (Solanaceae) was investigated for the induction of tumor using a soil borne bacterium, Agrobacterium tumefaciens. Explants like stem segments and nodes were infected with bacterium. Tumors were induced from nodal explants within 10 days of infection. These explants were then transferred to MS basal medium and their growth was observed to be independent of exogenous supply of phytohormones. The growth rate of transformed callus was 10-fold as compared to control. They are used as a promising source of secondary metabolites of medicinal significance.

Artificial intelligence can detect subtle changes in animal health before they become apparent through conventional observation. This chapter examines machine learning, deep learning and predictive analytics for livestock disease prediction and diagnosis. Models use physiological signals, diagnostic images, behaviour patterns, environmental conditions and historical records to recognize abnormalities and estimate disease risk. Wearable sensors and IoT devices enable continuous monitoring and early-warning systems, supporting preventive veterinary care and outbreak management. AI-based detection can reduce mortality, treatment costs and production losses while improving decision-making. The chapter also evaluates challenges involving inconsistent data, model interpretability, rural infrastructure, technical accessibility and the practical implementation of diagnostic systems.

ABSTRACT

A low molecular weight antifungal protein has been purified from the leaves of a medicinal herb, Mentha viridis, L. using a combination of cold acetone precipitation, carboxymethyl cellulose column, Q-sepharose column chromatography, and preparatory native PAGE techniques. The purified protein migrated as a single band on SDS-PAGE, with a molecular weight of ca 15.5 kDa. The purified leaf protein of M. viridis inhibited mycelial growth of phytopathogens such as Fusarium solani, Fusarium sp., and Pythium aphanidermatum. The purified protein from the leaves of M. viridis inhibited the growth of human pathogens such as Candida albicans and C. tropicalis (75 mg/mL). This inhibition is concentration dependent. The purified antifungal protein of leaves of M. viridis did not show protease, chitinase, and b-1, 3 glucanase activity.

Combination of an opioid (butorphanol/buprenorphine) and an alpha-2 agonist (xylazine/dexmedetomidine) along with an NMDA antagonist and benzodiazepine (tiletamine-zolazepam or ketamine-midazolam) will make up a balanced anaesthetic cocktail. Examples for balanced anaesthetic cocktails are xylazine/dexmedetomidine-butorphanol-midazolam-ketamine and butorphanol/ buprenorphine-tiletamine zolazepam-dexmedetomidine/xylazine (Ko, 2013; Cagle et al., 2017; Sooryadas et al., 2019; Verma et al., 2020). The latter ones are costly due to the tiletamine-zolazepam and dexmedetomidine in them, while the former ones are cost effective alternatives.
Xylazine/Dexmedetomidine-Butorphanol-Midazolam-Ketamine (XBMK/DBMK) Anaesthetic Cocktail
The preparation can be made by drawing 0.1 ml/kg of ketamine (50 mg/ml presentation) along with 0.1 to 0.2 ml/kg of the xylazine-butorphanol-midazolam (XBM) or dexmedetomidine-butorphanol-midazolam (DBM) sedative cocktail in a single syringe. For intravenous administration, 0.1 ml/kg each of ketamine and the sedative cocktail is to be chosen, while for intramuscular administration 0.1 ml/kg of ketamine and 0.2 ml/kg of the sedative cocktail is preferred. The volume of the cocktail that needs to be administered intramuscularly will be larger by 0.1 ml/kg when compared to the tiletamine-zolazepam based anaesthetic cocktails. Anticholinergic premedication is preferred prior to administration of anaesthetic cocktail containing xylazine (Nesgash et al., 2016), particularly if given intravenously. The XBMK/DBMK anaesthetic cocktails will induce anaesthesia in a few minutes, which last for 20 to 40 minutes (Ko, 2013; Verma et al., 2019; Verma et al., 2020). Intravenous administration of the anaesthetic cocktail provides shorter duration of surgical plane of anaesthesia. When administered as said above, the combination provides xylazine @ 0.2 - 0.4 mg/kg or dexmedetomidine @ 2.5 - 5 mcg/kg, butorphanol @ 0.1 - 0.2 mg/kg, midazolam @ 0.125 - 0.25 mg/kg and ketamine @ 5 mg/kg body weight which is as per their recommended doses when given in combination (Verma et al., 2019; Verma et al., 2020).

Analytical methods development and validation play important roles in the discovery, development, and manufacture of pharmaceuticals.

Pharmaceutical products formulated with more than one drug, typically referred to as combination products, are intended to meet previously unmet patients need by combining the therapeutic effects of two or more drugs in one product. These combination products can present daunting challenges to the analytical chemist responsible for the development and validation of analytical methods. This presentation will discuss the development and validation of analytical method (Spectrophotometric, High performance liquid chromatography (HPLC), & High performance thin layer chromatography (HPTLC)) for drug products containing more than one active ingredient. The official test methods that result from these processes are used by quality control laboratories to ensure the identity, purity, potency, and performance of drug products.

Animal behaviour provides valuable information about health, welfare, reproduction, environmental adaptation and social interaction. Traditional observation is labour-intensive, time-consuming and vulnerable to observer bias. This chapter explains how machine learning automates behavioural analysis using video, sensor and bioacoustic data. It covers preprocessing, feature extraction, classification, clustering and recurrent neural networks for temporal analysis. Computer-vision techniques—including object detection, tracking and pose estimation—enable continuous and non-invasive monitoring. Case studies demonstrate applications in livestock management, wildlife conservation and laboratory research. The chapter also examines data labelling, model generalization, ethics, explainable AI, real-time processing and the integration of multiple behavioural data sources

Veterinary oncology is an upcoming field in recent years due to the integration of the importance of spontaneous canine cancers in understanding and developing novel strategies for human cancer management. We are stepping towards a very exciting era in veterinary oncology, where comparative oncology has played a significant role for many decades in understanding the molecular basis of cancer in companion animals. The comparative animal models have generated remarkable interest in both academia and industry. Studies have demonstrated the utility of comparative oncology in understanding drug resistance and tumor biology, contributing to the translational research[1]. This has yielded breakthrough discoveries, from advanced diagnostics to novel therapies, providing opportunities to improve the longevity and quality of life of the pets. These inputs have led to advancements such as the first conditionally approved chemotherapeutic agent for lymphoma, novel BRAF testing for canine urothelial carcinoma, tyrosine kinase inhibitors for mast cell tumors, updates in stereotactic/FLASH radiation, and novel immunotherapeutics. As the understanding of cancer biology has advanced, the field of veterinary oncology has grown significantly, paralleling developments in human oncology. Veterinary oncologists treat a variety of cancers in domestic animals, particularly dogs and cats, but also in exotic animals, horses, and even zoo animals. While the types of cancers in animals share similarities with human cancers, treatment strategies can differ significantly due to species-specific differences in anatomy, physiology, and response to therapies [2, 3].

1. Introduction

Medicinal plants continue to be an important therapeutic aid for alleviating the ailments of humankind. The search for eternal health and longevity for remedies to relive pain and discomfort drove early man to explore his immediate natural surroundings to the use of many plants, animal products and minerals etc for the development of a variety of therapeutic agents. Today, there is a renewed interest in traditional medicine and an increasing demand for more drugs from plants sources. This revival of interest in plant derived drugs is mainly due to the current widespread belief that “green medicine” is safe and more dependable than the costly synthetic drugs, many of which have adverse side effects.

Vitex negundo or Five-Leaved Chaste Tree is commonly known as Nirgundi in India. It is a large aromatic shrub belonging to the Verbenaceae family of plants. It is distributed throughout the greater part of India up to an altitude of 1500 m in the outer Himalayas. It is a gregarious shrub that is found abundant along the banks or rivers, in moist situations, open waste lands and near the deciduous forests. It is widely planted as a hedge plant along the roads and between the roads.

1. Introduction

The discovery and development of antibiotics have led to dramatic improvement in the ability to treat infectious diseases with emergence of drug – resistant organisms due to irrational and overuse of antibiotics, failure to complete a course of treatment, genetic versatility of microbes and horizontal transfer of resistant genes among bacterial species had led to antibiotic resistance (Amit and Shailendra, 2006; Aibinu, 2007).The need for alternative antimicrobial agents has renewed the interest on plants as a sources of antimicrobial agents due to their use historically and the fact that a good portion of the world’s population, particularly in developing countries, rely on plants for the treatment of infectious and non-infectious diseases.
 
Syzygium aromaticum

Clove (Syzygium aromaticum) is the aromatic dried flower buds of a tree in the family Myrtaceae. The traditional use indicates that Clove has several therapeutic properties, such as an aphrodisiac, stomach, carminative, nervous stimulant and tonic. Reports has been documented  on their aphrodisiac, antibacterial, antifungal, nematocidal, anti-toothache, anti-oxidant, analgesic, anesthetic and hypotensive properties. Although in Iranian traditional medication several formulation containing clove have been used as a nervous stimulant and cognitive enhancer. (Mohammad, et al., 2009).

Introduction
The discovery and widespread use of antibiotics in the mid-20th century marked a transformative era in modern medicine, enabling life-saving interventions in surgery, transplantation, and critical care. Diseases once considered fatal became manageable, and the global burden of infectious diseases significantly declined. However, the remarkable success of antibiotics has been increasingly overshadowed by the rapid rise of antimicrobial resistance (AMR), now recognized by the World Health Organization (WHO) as one of the most serious threats to global health, food security, and sustainable development. Resistant infections already contribute to longer hospital stays, increased healthcare costs, and elevated mortality rates. Alarmingly, if current trends continue, AMR-related deaths are projected to exceed those caused by cancer by 2050.A pivotal yet often underestimated factor in the persistence and spread of AMR is the formation of microbial biofilms. Biofilms are highly organized, surface-attached communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) composed of proteins, polysaccharides, lipids, and nucleic acids. This matrix not only anchors microbial population but also confers protection against environmental stressors, immune responses, and antimicrobial agents. Bacteria within biofilms can withstand antibiotic concentrations up to 1000 times higher than their planktonic counterparts due to altered metabolic states, enhanced horizontal gene transfer, and activation of resistance mechanisms such as efflux pumps. Biofilms are implicated in over 80% chronic and device-associated infections, including those caused by ESKAPE pathogensAcinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Staphylococcus aureus. These infections are notoriously difficult to treat and often recur, posing significant clinical challenges. Beyond healthcare settings, biofilm formation in livestock and agricultural environmentsexacerbated using antibiotics as growth promoterscontributes to the emergence of resistant strains that can spread to humans via direct contact, environmental contamination, or the food chain.Understanding the multifaceted resistance mechanisms within biofilms is essential for developing effective containment strategies. These include physical exclusion of antibiotics by the EPS matrix, metabolic dormancy, persister cell formation, quorum sensing-mediated coordination, and stress response activation. Moreover, biofilms often consist of multispecies communities, where interspecies interactions further enhance resilience.In response, antibiofilm agents have emerged as a promising frontier in AMR containment. These include natural compounds (e.g., antimicrobial peptides, essential oils), engineered materials (e.g., nanoparticles, surface coatings), quorum sensing inhibitors, efflux pump blockers, and enzymatic disruptors such as dispersin B and DNases. Ecological approaches like probiotics and positive biofilms offer preventive strategies in agriculture and food systems. Importantly, these agents aim to complement antibiotics by enhancing their efficacy rather than replacing them.Despite challenges in scalability, safety, and regulatory approval, antibiofilm strategies represent a paradigm shift in infection control. Their integration into clinical, veterinary, and environmental practicesaligned with the One Health frameworkis essential for preserving antibiotic effectiveness and mitigating the global AMR crisis.

Introduction
The discovery of antibiotics in the early 20th century revolutionized medicine, agriculture, and public health. These compounds, capable of inhibiting or destroying pathogenic bacteria, not only saved millions of human lives but also transformed animal production systems by reducing morbidity and mortality, improving growth rates, and ensuring food security (Phillips et al., 2004). The application of antibiotics in food animals,whether for therapeutic, prophylactic, or growth-promoting purposes,has been instrumental in increasing global meat, milk, egg, and fish production, thus addressing the nutritional needs of a growing population (Darwish et al., 2013; Chen et al., 2019). However, the indiscriminate and excessive use of antibiotics in animal agriculture has created unintended consequences, most notably the presence of antibiotic residues in foods of animal origin and the global acceleration of antimicrobial resistance (AMR) (Bacanli & Basaran, 2019; Shahid et al., 2021). Antibiotic residues in food is the trace amounts of active compounds or its metabolites that remain in edible animal tissues, milk, eggs, and aquaculture products causes significant concerns for both consumer safety and public health. Even when below the maximum residue limits (MRLs) established by regulatory authorities, prolonged exposure may lead to allergic reactions, disruption of the gut microbiome, reproductive and developmental toxicity, mutagenicity, nephropathy, and in certain cases carcinogenicity (Ngangom et al., 2019; WHO, 2020). Furthermore, residues contribute to the selection pressure that drives the emergence and dissemination of resistant bacterial strains in humans, animals, and the environment (FAO, 2019; O’Neill, 2016). The One Health framework highlights these interconnected pathways, recognizing food as a critical link between veterinary antibiotic use and human AMR burden (Robinson et al., 2016). Globally, approximately 73% of antibiotics are consumed in food animal production, with projections estimating a further 11–67% increase by 2030,largely by intensification of livestock and aquaculture in developing economies (Van Boeckel et al., 2015; Tiseo et al., 2020). While industrialized nations have implemented bans on antibiotic growth promoters and introduced robust surveillance programs, most low- and-middle-income countries still facing challenges (Antibiotics, 2021; WHO, 2019). Consequently, foods containing antibiotic residues frequently enter local and international markets, undermining food safety standards and exacerbating AMR risks (Darwish et al., 2013; Antibiotics, 2021). Antimicrobial resistance (AMR) has emerged as a major global public health crisis, directly causing an estimated 1.27 million deaths and contributing to nearly 5 million deaths worldwide in 2019. Recognizing its severity, the World Health Organization (WHO) has identified AMR as one of the top ten threats to global health(Murray et al., 2022). By 2050, global economic losses linked to AMR are projected to reach USD 100–210 trillion, with Asia bearing a disproportionate mortality burden (O’Neill, 2016). Countries like India, with large livestock populations, rapidly growing aquaculture industries, and high human antibiotic consumption, represent critical hotspots where food, health, and environmental risks intersect (Chauhan et al., 2018; ICMR, 2020). Given these alarming trends, understanding the occurrence, detection, and consequences of antibiotic residues in foods of animal origin is paramount. This chapter explores the co-relationship between origin of antibiotic residues and AMR, regulatory measures aimed to safeguard food safety and strategies for prevention and control, framed within the One Health approach.

1.    ———— is a synthetic antimicrobial drug against M. tuberculosis.
    A.    Penicillin    B.    Tetracycline
    C.    Erythromycin    D.    Isoniazid
Ans.    D.
2.    Which of the antibiotic is not used as a food preservative ?
    A.    Pimaricin    B.    Nisin
    C.    Tylosin    D.    b-lactam antibiotic
Ans.    D.
3.    Which of the following bacteria is susceptible to thiophen-2-carboxylic acid hydrazide?
    A.    M. bovis    B.    M. tuberculosis
    C.    M. chelonei    D.    M. fortuitum
Ans.    A.

ABSTRACT

Three medicinal plants namely, Eryngium foetidum (Apiaceae), Centella asiatic (Apiaceae) and Hemidesmus indicus (Asclepiadaceae) were collected from Similipa Biosphere Reserve forest and used in this investigation. Ethanolic, methanolic chloroform and aqueous extracts of different parts like leaf, root and stem were prepare through standard techniques and screened for their anticandidal potencies agains Candida albicans, C. tropicalis and C. krusei. Anticandidal activity of the extracts wer tested using preliminary and secondary screening methods, like disc diffusion metho (DDM) & agar-cup-plate-method (ACPM) and poisoned food technique (PFT respectively. On an average the inhibitory tendency of the extracts can be arranged as ethanolic extracts > methanolic extacts > chloroform extracts > aqueous extracts Maximum degree of inhibition was observed against C. krusei. Among the plant Hemidesmus indicus showed better anticandidal activities in comparison to other tw plants tested.

1. Introduction

Nothing in the universe is non medicinal everything has its value in its own way. Infectious diseases are an important health hazard all over the world, both in developing and developed countries. Several synthetic antibiotics are employed in the treatment of infectious and communicable diseases. A number of researchers nowadays are working seriously to find out substitutes for antibiotics as they cause side effects on the functioning of different parts of the body organs and systems. Antibiotics are also known to disturb the natural intestinal micro flora, thus depriving the benefits of these microbes to human body. Medicinal plants exhibit antimicrobial activity since they contain innumerable biologically active chemical constituents. The medicinal plant wealth, the strong and time tested traditional medicare systems like ayurveda and the human resource base are the strengths of India. Over the last forty years intensive efforts have been made to discover clinically useful antibacterial/ antifungal drugs (Sashikumar et al., 2003). Over 50% of all modern clinical drugs are of natural product origin (Ates, 2003). Higher plants as sources of medicinal compounds have continued to play a dominant role in the maintenance of human health since ancient times (Farombi, 2003).

ABSTRACT

Indole alkaloids gramine, tyramine and tryptamine were isolated from the aerial part of Cynodon dactylon (L.) Pers. for the first time and their antimicrobial properties agains microbial pathogens were studied. Structures of the compounds were elucidated base upon the spectroscopic data such as ¹H-NMR, ¹³C- NMR and MS. The evaluations o the crude extract and the alkaloids for their efficacy in inhibiting the growth of huma pathogenic bacteria and dermatophytes were carried out in vitro. The crude extrac was effective in inhibiting the growth of all the tested microorganisms. Tryptamin and tyramine did not inhibit microbial growth when tested individually, but in combination the growth inhibition of Klebsiella pneumoniae was prominent. Gramin was the most effective one in inhibiting the growth of all the tested microbial pathogens

ABSTRACT

In this study, different concentrations of acetone, alcohol, benzene and chloroform extract of Wedelia chinensis were carried out against human pathogenic bacterial and fungal strains. High frequency of anti-bacterial activity was observed on the Escherichia coli. Moderate amount of antibacterial activity was observed on Staphylococcus aureus. Highly resistant bacterium to this plant was screened through antibacterial pour plate method, which showed on the following organisms Citrobacter diversens, Serratia marcescens and Streptococcus pyogenes. The aim of this study is main evaluation of antimicrobial activity of plant. The ethanolic extracts demonstrating antibacterial and antifungal activity could result in the discovery of antibacterial and antifungal agents.

Introduction 
Antimicrobial resistance (AMR) is one of the most significant global health challenges of the 21st century. Defined as the ability of microorganisms— including bacteria, viruses, fungi, and parasites—to resist the effects of antimicrobial drugs, AMR undermines the progress of modern medicine. Antimicrobials—including antibiotics, antivirals, antifungals, and antiparasitics—are the cornerstone of modern medicine. Their discovery transformed the treatment of infectious diseases and enabled surgical advances, chemotherapy, and organ transplantation. However, Alexander Fleming, the discoverer of penicillin, warned that misuse could render these drugs ineffective. Antibiotics, since their discovery in the 20th century, revolutionized healthcare, saving millions of lives and enabling complex medical procedures. Yet, the misuse and overuse of antimicrobials in human health, veterinary practices, and agriculture have rapidly accelerated the emergence of resistant organisms. Today, this warning has materialized as a global crisis. Antimicrobial resistance (AMR) is now considered one of the top ten public health threats by the World Health Organization (WHO). It is not only a biomedical issue but also a socio-economic and developmental challenge. This chapter aims to provide an in-depth overview of AMR, focusing on definitions, history, mechanisms, causes, global status, impacts, and the urgency of mitigation efforts. It also explores national and global responses and future directions to curb the spread of AMR. AMR is estimated to cause 700,000 deaths annually worldwide, with projections of 10 million deaths annually by 2050 if urgent interventions are not implemented. In addition to health impacts, AMR poses grave threats to food security, sustainable agriculture, economic stability, and global development. This chapter provides a comprehensive overview of AMR, including definitions and conceptual frameworks, historical background, mechanisms of